Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 664 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Eikon Therapeutics, Inc. Common Stock
Market Cap
$420.39M
Operating Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$415.84M
Operating Margin
0.00%
TTM Avg
-4465.14%
3Y Avg
-2232.57%
5Y Avg
-1488.38%
Market Cap
$413.34M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.78%
Market Cap
$412.90M
Operating Margin
-58.53%
TTM Avg
-50.96%
3Y Avg
-52.76%
5Y Avg
-52.76%
Market Cap
$398.58M
Operating Margin
-12.22%
TTM Avg
-9.37%
3Y Avg
-14.04%
5Y Avg
-19.79%
Market Cap
$403.02M
Operating Margin
-61.09%
TTM Avg
-74.66%
3Y Avg
-94.75%
5Y Avg
-94.75%
Market Cap
$429.11M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
Market Cap
$438.13M
Operating Margin
-245.15%
TTM Avg
-511.19%
3Y Avg
-596.30%
5Y Avg
-548.32%
Market Cap
$442.77M
Operating Margin
-15.26%
TTM Avg
-21.73%
3Y Avg
-43.66%
5Y Avg
-43.15%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eikon Therapeutics, Inc. Common Stock (EIKN) | $420.39M | 0.00% | N/A | N/A | N/A |
| Neurogene Inc. (NGNE)vs › | $415.84M | 0.00% | -4465.14% | -2232.57% | -1488.38% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $413.34M | 0.00% | 0.00% | 0.00% | 2.78% |
| Shoulder Innovations, Inc. (SI)vs › | $412.90M | -58.53% | -50.96% | -52.76% | -52.76% |
| Myriad Genetics, Inc. (MYGN)vs › | $398.58M | -12.22% | -9.37% | -14.04% | -19.79% |
| Carlsmed, Inc. (CARL)vs › | $403.02M | -61.09% | -74.66% | -94.75% | -94.75% |
| NeoGenomics, Inc. (NEO)vs › | $429.11M | -8.63% | -11.52% | -18.04% | -16.64% |
| Editas Medicine, Inc. (EDIT)vs › | $438.13M | -245.15% | -511.19% | -596.30% | -548.32% |
| NeuroPace, Inc. (NPCE)vs › | $442.77M | -15.26% | -21.73% | -43.66% | -43.15% |
| Assembly Biosciences, Inc. (ASMB)vs › | $442.52M | -11.75% | -88.01% | -269.63% | -547.01% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
